Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001140361-26-036125

Chief Executive Officer bought 100,000 shares at $2.14 ($214,000)

From the SEC's structured data for this filing

Trades in this filing

Kohli Prashant · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-09 Purchase : show line 1 in the form +100,000 $2.14 $214,000 121,357 D
Open-market purchases · 100,000 sh · avg $2.14 · $214,000
Loading xslF345X06/form4.xml…